Vitiligo Prevalence and Patient Burden

John E. Harris, MD, PhD, reviews factors that shape prevalence of vitiligo and also explores the impact of vitiligo on patient quality of life.

Related Videos
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
John Harris, MD, PhD: Year 1 of Ruxolitinib Cream for Vitiligo
Brett King, MD, PhD: Following Up the Ruxolitinib Cream Approval for Vitiligo
Related Content
© 2023 MJH Life Sciences

All rights reserved.